aResearch Institute of Internal Medicine, Oslo University Hospital Rikshospitalet, Oslo, Norway bFaculty of Medicine, Institute of Clinical Medicine, University of Oslo, Oslo, Norway cDepartment of ...
Icotrokinra met the primary endpoint of clinical response at all three doses, with 36.5% of patients treated achieving endoscopic improvement and 30.2% achieving clinical remission at the highest dose ...
Incheon, South Korea Monday, October 6, 2025, 16:00 Hrs [IST] Celltrion, Inc. announced that Avtozma (tocilizumab-ano ...
I Department of Translational Medicine, The John Curtin School of Medical Research, The Australian National University, Canberra, Australia II Endocrinology and Diabetes Research Unit, Australian ...
TARGETING IL-6 signaling shows reassuring safety and effectiveness in older patients with rheumatoid arthritis (RA), according to recent postmarketing and registry data. IL-6 plays a central role in ...
Watch our FDA pipeline news recap for the month for August 2025, as well as a preview of PDUFA dates listed for September. Welcome to FDA Focus, where we take you back and recap some of the top FDA ...
Discover the latest advancements in biosimilars, including tocilizumab's new indication, and partnerships for omalizumab and ranibizumab. The FDA expanded an indication for a tocilizumab biosimilar to ...
FDA expands tocilizumab-anoh's indication for treating cytokine release syndrome, enhancing treatment options for patients undergoing CAR T-cell therapy. The US FDA has approved an expanded indication ...
Earlier this year, the FDA approved AVTOZMA as a biosimilar to ACTEMRA in IV formulations for the treatment of multiple diseases including rheumatoid arthritis (RA), giant cell arteritis (GCA), ...
Autoimmune diseases stem from a complicated interplay of immune dysregulation, characterized by chronic inflammation and the loss of self-tolerance. Cytokines are central to these processes. These ...
State Key Laboratory of Oral Diseases, National Center for Stomatology, National Clinical Research Center for Oral Diseases, West China Hospital of Stomatology, Sichuan University, Chengdu 610041, P.
Peer ReviewDownload a summary of the editorial decision process including editorial decision letters, reviewer comments and author responses to feedback. Preterm birth (PTB) is a major cause of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback